The typical case for the fund is to invest in rounds with 3-4 participants. The meaningful sponsors for the fund in investment in the same round are Oriza Seed Capital (Oriza Yuandian), Decheng Capital, Craig Fletcher. In the next rounds fund is usually obtained by South China Venture Capital, Sherpa Venture Capital, SDIC Fund Management.
Among the most popular portfolio startups of the fund, we may highlight EpimAb Biotherapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Software Engineering.
The overall number of key employees were 1.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Fund Name | Location |
Accelerate Long Island | Melville, New York, United States |
AMKA Holdings | Canada, Ontario, Toronto |
Arab Bank (Switzerland) | Geneva, Geneve, Switzerland |
BioSciKin | - |
Coghill Capital Management | Chicago, Illinois, United States |
Coris Bank International | Burkina Faso, Kadiogo, Ouagadougou |
CyRise | Australia, Melbourne, Victoria |
DPE Deutsche Private Equity | Bayern, Germany, Munich |
East Coast Ventures | - |
Elevance Renewable Sciences | Illinois, United States, Woodridge |
i-nest capital | Japan, Tokyo |
Lauxera Capital Partners | France, Ile-de-France, Paris |
Monex Precious Metals | California, Newport Beach, United States |
Roma Way | China, Harbin, Heilongjiang |
SeedRocket 4Founders Capital | Barcelona, Catalonia, Spain |
ShoreTel | California, Sunnyvale, United States |
Smartforce | - |
Talkot Capital | California, Sausalito, United States |
Varagon Capital Partners | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Mogrify | $10M | 02 Oct 2023 | Cambridge, England, United Kingdom | ||
MindImmune Therapeutics | $12M | 30 Jun 2022 | Rhode Island, United States | ||
Senisca | $2M | 09 Jun 2022 | Exeter, England, United Kingdom | ||
PragmatIC Semiconductor | 01 Jan 2022 | Cambridge, England, United Kingdom | |||
Mogrify | 03 Sep 2021 | Cambridge, England, United Kingdom | |||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
PhoreMost | $45M | 23 Mar 2021 | Cambridge, England, United Kingdom | ||
$1M | 05 Mar 2021 | Exeter, England, United Kingdom | |||
Keythera Pharmaceuticals | 12 Feb 2021 | Gusu District, Jiangsu, China |
– PhoreMost is a Cambridge, England, UK-based biopharmaceutical company.
– The company raised $46m in Series B funding.
– The round was led by BGF, and included new investor – XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures.
– Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Mogrify | $10M | 02 Oct 2023 | Cambridge, England, United Kingdom | ||
MindImmune Therapeutics | $12M | 30 Jun 2022 | Rhode Island, United States | ||
Senisca | $2M | 09 Jun 2022 | Exeter, England, United Kingdom | ||
PragmatIC Semiconductor | 01 Jan 2022 | Cambridge, England, United Kingdom | |||
Mogrify | 03 Sep 2021 | Cambridge, England, United Kingdom | |||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
PhoreMost | $45M | 23 Mar 2021 | Cambridge, England, United Kingdom | ||
$1M | 05 Mar 2021 | Exeter, England, United Kingdom | |||
Keythera Pharmaceuticals | 12 Feb 2021 | Gusu District, Jiangsu, China |